FDA Expands Indication for EVARRESTĀ® Fibrin Sealant Patch
Go back to FDA Expands Indication for EVARRESTĀ® Fibrin Sealant Patch| Johnson & Johnson (NYSE: JNJ) | Delayed: 256.98 -2.12 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.10 | 52 Week High | $126.07 | |||
| Open | $260.19 | 52 Week Low | $94.28 | |||
| Day High | $261.30 | P/E | 53.43 | |||
| Day Low | $255.52 | EPS | $4.81 | |||
| Volume | 6,539,033 | |||||

